These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8070763)

  • 1. [Detection of isoferritin level in breast cancer tissue and serum].
    Cai G; Zeng W; Chen P; Lü S; Zhao Y; Yang H
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):15-7. PubMed ID: 8070763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ELISA of serum isoferritin and its clinical application].
    Cai G; Zeng W; Lu S; Chen P; Zhao Y; Cai Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Sep; 23(4):367-9. PubMed ID: 1338991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of serum isoferritin level in 195 patients with cancer].
    Cai G; Wei L; Lü S; Hao D; Li Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):395-7. PubMed ID: 8732059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observation of the serum acidic isoferritin levels in patients with hepatocellular carcinoma].
    Zou L; Hao D; Cai G; Wei L
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Dec; 28(4):424-7. PubMed ID: 10683960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody CM-H-9 detects circulating placental isoferritin in the serum of patients with visceral metastases of breast cancer.
    Rosen HR; Flex D; Stierer M; Moroz C
    Cancer Lett; 1991 Aug; 59(2):145-51. PubMed ID: 1884372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum placental isoferritin and breast cancer prognosis.
    Stierer M; Rosen HR; Moroz C
    Breast Cancer Res Treat; 1990 Nov; 17(1):63. PubMed ID: 2095930
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytosol and serum ferritin in breast carcinoma.
    Güner G; Kirkali G; Yenisey C; Töre IR
    Cancer Lett; 1992 Dec; 67(2-3):103-12. PubMed ID: 1483258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
    Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W
    Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental isoferritin measured by a specific monoclonal antibody as a predictive marker for preterm contraction outcome.
    Maymon R; Bahari C; Moroz C
    Obstet Gynecol; 1989 Oct; 74(4):597-9. PubMed ID: 2797636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer.
    Rosen HR; Moroz C; Reiner A; Reinerova M; Stierer M; Svec J; Schemper M; Jakesz R
    Breast Cancer Res Treat; 1992; 24(1):17-26. PubMed ID: 1463868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of human cardiac acidic isoferritin: a new index for hepatic cancer.
    Jin J; Zhang M; Wang B; Xiao H; Sun J
    Chin Med J (Engl); 1998 Feb; 111(2):150-3. PubMed ID: 10374377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of plasma placental isoferritin in pathogenesis of preeclampsia and its predictive value for preeclampsia].
    Wang Z; Zhu Y
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):209-11. PubMed ID: 11783362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microheterogeneity of human liver and serum ferritins measured on minute amounts of ferritin in crude samples.
    Zuyderhoudt FM; Linthorst C
    Ann Clin Biochem; 1984 Nov; 21 ( Pt 6)():471-6. PubMed ID: 6517485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoferritin composition of tissues and serum in human cancers.
    Halliday JW; McKeering LV; Powell LW
    Cancer Res; 1976 Dec; 36(12):4486-90. PubMed ID: 11886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serum HER-2 oncoprotein and patients with breast cancer.
    Yuan P; Xu BH; Chu DT
    Chin Med Sci J; 2004 Sep; 19(3):212-5. PubMed ID: 15506651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1.
    Jänicke F; Pache L; Schmitt M; Ulm K; Thomssen C; Prechtl A; Graeff H
    Cancer Res; 1994 May; 54(10):2527-30. PubMed ID: 8168072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.
    You SY; Zhang CY; Yi XP; Huang W
    Hybridoma; 2001 Aug; 20(4):243-8. PubMed ID: 11604110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue ferritin concentration in carcinoma of the breast.
    Weinstein RE; Bond BH; Silberberg BK
    Cancer; 1982 Dec; 50(11):2406-9. PubMed ID: 7139533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p43 in breast cancer tissue, correlation with prognostic parameters.
    Rosen HR; Moroz C; Reiner A; Stierer M; Svec J; Reinerova M; Schemper M; Jakesz R
    Cancer Lett; 1992 Oct; 67(1):35-45. PubMed ID: 1423243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of serum CEACAM1 as a potential biomarker for breast cancer.
    Yang C; He P; Liu Y; He Y; Yang C; Du Y; Zhou M; Wang W; Zhang G; Wu M; Gao F
    Clin Chim Acta; 2015 Oct; 450():277-81. PubMed ID: 26343926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.